Top compounds associated with response to KLF2


Feature Type Standardized
Nominal ANOVA
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.078 0.005
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.1 0.005
mRNA ceranib-2 CTRPv2 pan-cancer AAC -0.09 0.006
mRNA AZD-2281 CTRPv2 pan-cancer AAC -0.094 0.006
mRNA Methotrexate CTRPv2 pan-cancer AAC -0.1 0.006
mRNA XMD15-27 GDSC1000 pan-cancer AAC 0.096 0.006
mRNA Gefitinib GDSC1000 pan-cancer AAC -0.091 0.006
mRNA GDC-0449 GDSC1000 pan-cancer AAC -0.099 0.007
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.098 0.007
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.095 0.007
Download CSV